P16 protein in cervical and endometrial adenocarcinoma differential diagnosis of adenocarcinoma.doc

P16 protein in cervical and endometrial adenocarcinoma differential diagnosis of adenocarcinoma.doc

  1. 1、本文档共16页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
P16 protein in cervical and endometrial adenocarcinoma differential diagnosis of adenocarcinoma

 PAGE \* MERGEFORMAT 16 P16 protein in cervical and endometrial adenocarcinoma differential diagnosis of adenocarcinoma [Abstract] Objective To observe the p16 protein in cervical adenocarcinoma and endometrial adenocarcinoma and its significance in differential diagnosis. But will also guide the clinical part of the early cases the need to retain reproductive function. Methods Immunohistochemistry chemical SP method detected in 40 cases of cervical adenocarcinoma and 73 cases of endometrial adenocarcinoma in the p16, p53, ER and PR expression. Results (1p16 in 40 cases of cervical adenocarcinoma in 37 patients (92.5% showed diffuse positive, in 73 cases of endometrial adenocarcinoma in 28 cases (38.4% were focally positive. (2 in cervical adenocarcinoma in the p53, ER, PR positive expression of each 20.0%, 5.0%, 7.5% in endometrial cancer, 38.4% in the expression of p53-positive, hormone receptor ER, PR in endometrial adenocarcinoma were 78.1%, 71.2% of expression. p16 protein in cervical adenocarcinoma showed diffuse nuclear and cytoplasmic positive, but histology Similar endometrial morphology and irregular focal positive for adenocarcinoma, and the overall intensity is weak. p16 protein in both the United p53 protein detection, hormone receptors ER, PR will not only be able to identify cervical cancer and endometrial cancer, can also be used for uterine serous carcinoma and differential diagnosis of endometrial adenocarcinoma. Conclusion of uterine cancer biopsy or curettage specimens, p16 protein detection can be used as a complementary immunohistochemical markers to identify cervical cancer and endometrial adenocarcinoma. [Keywords:] cervical adenocarcinoma, the differential diagnosis of endometrial adenocarcinoma p16 [Abstract] Objective: TObjectives Observation of p16 protein in cervical adenocarcinoma and endometrial cancer in the differential diagnosis of significance. Also part of the guideline on early cases whether the fertility pres

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档